ICS/LABA combination dominates Australian asthma treatment

Australians using an inhaled corticosteroid for asthma are almost twice as likely as New Zealanders to take it in combination with a long-acting beta agonist but disease control is equally poor in both countries, new research has shown. The study from the Woolcock Institute found that 61% of Australians used an ICS-containing inhaler compared to ...

Already a member?

Login to keep reading.

© 2021 the limbic